Conversion from tacrolimus to everolimus with complete and early glucocorticoid withdrawal after kidney transplantation: a randomised trial.

Bouamar, R; Shuker, N; Osinga, J A J; Clahsen-van Groningen, M C; Damman, J; Baan, C C; van de Wetering, J; Rowshani, A T; Kal-van Gestel, J; Weimar, W; van Gelder, T; Hesselink, D A

Bouamar, R; Shuker, N; Osinga, J A J; Clahsen-van Groningen, M C; Damman, J; Baan, C C; van de Wetering, J; Rowshani, A T; Kal-van Gestel, J; Weimar, W; van Gelder, T; Hesselink, D A.

Affiliation

Bouamar R; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands.

Neth J Med ; 76(1): 14-26, 2018 01.

Article in En | MEDLINE | ID: mdl-29380728

Subject(s)

Drug Substitution/adverse effects; Everolimus/administration & dosage; Glucocorticoids/administration & dosage; Graft Rejection/chemically induced; Immunosuppressive Agents/administration & dosage; Kidney Transplantation; Tacrolimus/administration & dosage; Adult; Aged; Female; Humans; Living Donors; Male; Middle Aged; Postoperative Period; Prospective Studies; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Tacrolimus / Drug Substitution / Everolimus / Glucocorticoids / Graft Rejection / Immunosuppressive Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neth J Med Year: 2018 Document type: Article

Search on Google

XML

PubMed Links